InsiderTrades

Form 4 for UTHR UNITED THERAPEUTICS Corp

Accepted 2022-04-08 00:00:00 ET · period of report 2022-04-07 · accession 0001415889-22-003958 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-04-08 2022-04-07 UTHR MAHON PAUL A EVP, GC M - OptEx $111.00 +6,000 42.5K +16% +$666.0K
DM 2022-04-08 2022-04-07 UTHR MAHON PAUL A EVP, GC S - Sale+OE $185.51 -6,000 37.7K -14% -$1.11M
D 2022-04-08 2022-04-07 UTHR MAHON PAUL A EVP, GC M - OptEx $0.00 -6,000 46.6K -11% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-04-07 M A 6,000 $111.00 42,487 D — —
2 Common Common Stock 2022-04-07 S D 1,200 $186.50 36,487 D — — (F4) This transaction was executed in multiple trades at prices ranging from $186.40 to $186.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3 Common Common Stock 2022-04-07 S D 2,914 $184.93 39,573 D — — (F2) This transaction was executed in multiple trades at prices ranging from $184.31 to $185.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
4 Common Common Stock 2022-04-07 S D 1,886 $185.79 37,687 D — — (F3) This transaction was executed in multiple trades at prices ranging from $185.33 to $186.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
5 Derivative Stock Options 2022-04-07 M D 6,000 $0.00 46,552 D $111.00 · 2021-03-15 to 2028-03-15 6,000 Common Stock (F5) These performance-based stock options were initially awarded on March 15, 2018, subject to a three-year performance condition tied to average cash profits during 2018-2020, and vested on March 15, 2021.